Michael Chin

Michael Chin has worked in the biotechnology and pharmaceutical industry since 1990. Michael began their career at Protos as an Associate Scientist in 1990. Michael then moved to Bristol-Myers Squibb in 1991, where they held the role of Associate Scientist. In 1994, they joined Chiron Corporation as a Scientist II. In 2006, they began working at Novartis Institutes for BioMedical Research (NIBR) as an Investigator. In 2008, they moved to Pfizer - Cancer Immunology, where they held the roles of Associate Research Fellow and Senior Principal Scientist. Most recently, in 2019, they joined Asher Biotherapeutics as Senior Director, Protein Engineering.

Michael Chin attended the University of California, Berkeley.